NCT06314919招募中不适用
A Multicenter, Prospective, Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimibe Under the Real-World Condition
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 8,606
- 试验地点
- 1
- 主要终点
- Rate of reaching the target LDL Cholesterol level
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those who taking statins or statins and ezetimibe in addition to dietary and exercise therapy for primary hypercholesterolemia or mixed hyperlipidemia
- •Those who are judged to need administration of a fixed-dose combination of pitavastatin/ezetimibe for change of statin's formulation or change of statin's dose, addition of ezetimibe
排除标准
- •Those who are taking a fixed-dose combination of pitavastatin/ezetimibe at study enrollment
- •Those with hypersensitivity reactions or relevant medical history to pitavastatin or ezetimibe
- •Those who have been administered an investigational product within 12 weeks of the enrollment date or are planning to participate in another clinical trial during this study participation period.
结局指标
主要结局
Rate of reaching the target LDL Cholesterol level
时间窗: 12 weeks after administration
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)Diabetes Mellitus, Type 2NCT00728351Novartis Pharmaceuticals317
已完成
3 期
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in HypertensionHypertensionNCT05820880Institut de Recherches Internationales Servier532
已完成
不适用
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and DyslipidemiaHypertension and DyslipidemiaNCT04554953Boryung Pharmaceutical Co., Ltd10,877
已完成
3 期
Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.Essential HypertensionNCT05288400Servier150
已完成
4 期
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and VomitingNeoplasmsChemotherapy-Induced Nausea and VomitingNCT01481831Shanghai Changzheng Hospital599